Siddiqui, F.A.; Parkkola, H.; Vukic, V.; Oetken-Lindholm, C.; Jaiswal, A.; Kiriazis, A.; Pavic, K.; Aittokallio, T.; Salminen, T.A.; Abankwa, D.
Novel Small Molecule Hsp90/Cdc37 Interface Inhibitors Indirectly Target K-Ras-Signaling. Cancers 2021, 13, 927.
https://doi.org/10.3390/cancers13040927
AMA Style
Siddiqui FA, Parkkola H, Vukic V, Oetken-Lindholm C, Jaiswal A, Kiriazis A, Pavic K, Aittokallio T, Salminen TA, Abankwa D.
Novel Small Molecule Hsp90/Cdc37 Interface Inhibitors Indirectly Target K-Ras-Signaling. Cancers. 2021; 13(4):927.
https://doi.org/10.3390/cancers13040927
Chicago/Turabian Style
Siddiqui, Farid Ahmad, Hanna Parkkola, Vladimir Vukic, Christina Oetken-Lindholm, Alok Jaiswal, Alexandros Kiriazis, Karolina Pavic, Tero Aittokallio, Tiina A. Salminen, and Daniel Abankwa.
2021. "Novel Small Molecule Hsp90/Cdc37 Interface Inhibitors Indirectly Target K-Ras-Signaling" Cancers 13, no. 4: 927.
https://doi.org/10.3390/cancers13040927
APA Style
Siddiqui, F. A., Parkkola, H., Vukic, V., Oetken-Lindholm, C., Jaiswal, A., Kiriazis, A., Pavic, K., Aittokallio, T., Salminen, T. A., & Abankwa, D.
(2021). Novel Small Molecule Hsp90/Cdc37 Interface Inhibitors Indirectly Target K-Ras-Signaling. Cancers, 13(4), 927.
https://doi.org/10.3390/cancers13040927